News

Displaying 381 - 400 of 734

EMCDDA participates in RARHA project meeting on monitoring alcohol use and its consequences

Harmful and hazardous alcohol use is one of the main causes of premature deaths and avoidable diseases in the EU today. Highlighting the importance of this issue, the European Commission is funding...

EMCDDA participates in SEEA-net events

The EMCDDA is participating this week in the 7th Conference of the South Eastern European Adriatic (SEEA) Addiction Treatment Network and the 14th SEEA-net Symposium on Addictive Behaviours. Alexis Goosdeel, EMCDDA Head...

58th Commission on Narcotic Drugs, 9–17 March 2015, Vienna

The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body in drug-related matters, opens its 58th session in Vienna this week (9–17 March). The CND analyses the world drug...

image new drugs box and powder

EMCDDA presents latest update on ‘new drugs’ from EU Early Warning System

Among the public health concerns highlighted in the report are new synthetic opioids — often highly potent and sold as heroin to unsuspecting users — posing a high risk of overdose. Three...

Euro-DEN thumbnail

EMCDDA hosts Euro-DEN meeting and promotes guidelines: ‘When to call the emergency services for unwell recreational drug users’

The recreational drug scene has evolved rapidly over the last decade, with new psychoactive substances (NPS) posing additional challenges. However, at present, there is no robust pan-European system in place for capturing...

ECDC and EMCDDA release a joint rapid risk assessment on wound botulism among people who inject heroin

Today, two EU agencies, the European Centre for Disease Prevention and Control (ECDC) and the EU drugs agency (EMCDDA) have released a joint rapid risk assessment on wound botulism among people who...

EMCDDA welcomes new moves to make hepatitis C medications more accessible to patients

The EU drugs agency (EMCDDA) welcomes new moves to make hepatitis C medications more accessible to those affected by the virus in line with its previous statements. Hepatitis C is the most...

Picture of 2015 in neon

New EMCDDA annual work programme published today

A major task in 2015, also in cooperation with Europol, will be the preparation of the second EU drug markets report (for release in 2016). Further progress is also expected to be...

Example if customs laboratory

Customs Laboratories European Network (CLEN) meets in Lisbon

The Portuguese Taxes and Customs Authority and the EMCDDA are hosting in Lisbon this week the second meeting of the European Commission’s (EC) Customs Laboratories European Network (CLEN) project group, funded by...

Overdose thumbnail

Mortality among drug users in Europe

Drug use is one of the major causes of mortality among young people in Europe, both directly through overdose (drug-induced deaths) and indirectly through drug-related diseases, accidents, violence and suicide.

Internet thumbnail

New EMCDDA trendspotter study explores online supply of drugs

Social media were found to play an active role in drug markets, whether used directly for buying and selling drugs or indirectly for marketing, opinion-forming or experience-sharing. Smartphone apps were also seen...

European Parliament

Drug policies in the perspective of UNGASS 2016

EMCDDA Director Wolfgang Götz is at the European Parliament today for an exchange of views with European members of the Global Commission on Drug Policy ahead of the United Nations General Assembly...

Director presents highlights from EMCDDA 2015 work programme at European Parliament

EMCDDA Director Wolfgang Götz is at the European Parliament today where he is presenting to members of the Committee for Civil Liberties, Justice and Home Affairs (LIBE) highlights from the agency’s 2015...

New EMCDDA review studies the effectiveness of overdose antidote, naloxone

Can naloxone provided in the community help reduce the thousands of drug-induced deaths recorded in Europe every year? This is the question explored by the EU drugs agency (EMCDDA) in a new...

Registration opens for fourth European drugs summer school

The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces again this summer to hold the fourth European drugs summer school (EDSS) on 'Illicit drugs in...

Gaps in HIV prevention expose Europe to risk of outbreaks

In Europe, decades of investment in effective HIV prevention measures targeting people who inject drugs continue to bear fruit as demonstrated by the long-term decline in HIV diagnoses related to drug injecting...

Annual award ceremony to celebrate excellence in scientific writing on illicit drugs

The four winners of the 2014 EMCDDA scientific paper award will be honoured in Lisbon on 25 November at the fourth annual award ceremony hosted by the EU agency (1). The winners...

Third EMCDDA Reitox week

Candidate, potential candidate and neighbouring countries of the EU, preparing to collaborate with the EMCDDA, will participate in the third ‘Reitox week’ to be held in Lisbon from 25–28 November. This annual...

Pregnancy and opioid use: strategies for treatment

Illicit opioid consumption is associated with an increase in obstetric complications in pregnant women. It also brings with it a range of potential dangers for the child, both before and after birth...

Click and learn with the EMCDDA’s new-look Best practice portal

Real-life responses to drug problems come under the spotlight today as the EU drugs agency (EMCDDA) launches its revamped Best practice portal. Designed as a practical and reliable source of what works...